
BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy
BioNexus Gene Lab (BGLC) has adopted an Ethereum-focused treasury strategy, thus becoming the first Nasdaq-listed company to prioritize ETH. The exact percentage for its Ethereum allocation has not been divulged by the company but the move follows the leading altcoin’s inclusion in the US “Crypto Strategic Reserve.” BGLC Embraces Ethereum BGLC has released its Ethereum…